MX7533E - Procedimiento para preparar derivados de dihidropiridina - Google Patents

Procedimiento para preparar derivados de dihidropiridina

Info

Publication number
MX7533E
MX7533E MX8511595U MX1159585U MX7533E MX 7533 E MX7533 E MX 7533E MX 8511595 U MX8511595 U MX 8511595U MX 1159585 U MX1159585 U MX 1159585U MX 7533 E MX7533 E MX 7533E
Authority
MX
Mexico
Prior art keywords
different
same
alkyl groups
group
groups
Prior art date
Application number
MX8511595U
Other languages
English (en)
Inventor
Takashi Fujikura
Noriki Ito
Yuzo Matsumoto
Yasuo Isomura
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Publication of MX7533E publication Critical patent/MX7533E/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/82Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MX8511595U 1984-06-28 1985-06-28 Procedimiento para preparar derivados de dihidropiridina MX7533E (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59133650A JPS6112662A (ja) 1984-06-28 1984-06-28 ジヒドロピリジン誘導体及びその製法

Publications (1)

Publication Number Publication Date
MX7533E true MX7533E (es) 1989-08-15

Family

ID=15109748

Family Applications (2)

Application Number Title Priority Date Filing Date
MX8511595U MX7533E (es) 1984-06-28 1985-06-28 Procedimiento para preparar derivados de dihidropiridina
MX26687A MX26687A (es) 1984-06-28 1988-07-20 Procedimiento para la preparar derivados de dehidropiridina.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX26687A MX26687A (es) 1984-06-28 1988-07-20 Procedimiento para la preparar derivados de dehidropiridina.

Country Status (13)

Country Link
US (1) US4727082A (es)
EP (1) EP0167371B1 (es)
JP (1) JPS6112662A (es)
KR (1) KR900005019B1 (es)
AT (1) ATE61356T1 (es)
AU (1) AU569161B2 (es)
CA (2) CA1300157C (es)
DE (1) DE3581967D1 (es)
ES (3) ES8707933A1 (es)
GR (1) GR851568B (es)
MX (2) MX7533E (es)
PT (1) PT80714B (es)
SU (1) SU1342413A3 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8503427D0 (en) * 1985-02-11 1985-03-13 Ici Plc Basic compounds
GB8503425D0 (en) * 1985-02-11 1985-03-13 Ici Plc Alkanolamine derivatives
EP0276552A1 (en) * 1986-12-08 1988-08-03 Yamanouchi Pharmaceutical Co. Ltd. 1,4-dihydropyridine derivatives and their production
CA1312611C (en) * 1987-07-01 1993-01-12 Yamanouchi Pharmaceutical Co., Ltd. Pyridine derivatives, process for production thereof and pharmaceutical composition containing them
GB9102031D0 (en) * 1991-01-30 1991-03-13 Fujisawa Pharmaceutical Co Dihydropyridine compounds,and process for their preparation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2753946A1 (de) * 1977-12-03 1979-06-13 Bayer Ag 1-n-aryl-1,4-dihydropyridine und ihre verwendung als arzneimittel
US4285955A (en) * 1978-10-31 1981-08-25 Bayer Aktiengesellschaft 1,4-Dihydropyridinecarboxylic acids
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
DE3207982A1 (de) * 1982-03-05 1983-09-08 Bayer Ag, 5090 Leverkusen Neue 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihrer verwendung in arzneimitteln
HU192166B (en) * 1982-08-06 1987-05-28 Banyu Pharma Co Ltd Process for producing 2-carbamoyl-oxy-alkyl-1,4-dihydro-pyridine derivatives
US4500527A (en) * 1983-06-22 1985-02-19 Usv Pharmaceutical Corporation Antihypertensive 4[(3-alkylamino-2-hydroxypropyl)-oxyiminomethyl phenyl]-1,4-dihydropyridines
NO854021L (no) * 1984-10-26 1986-04-28 Bayer Ag 1,4-dihydropyridin-hydroksyaminer og fremgangsmaate til fremstilling derav.
GB8503425D0 (en) * 1985-02-11 1985-03-13 Ici Plc Alkanolamine derivatives

Also Published As

Publication number Publication date
JPS6112662A (ja) 1986-01-21
GR851568B (es) 1985-11-25
PT80714B (en) 1986-12-11
ES552335A0 (es) 1987-04-16
SU1342413A3 (ru) 1987-09-30
ES8704899A1 (es) 1987-04-16
EP0167371A2 (en) 1986-01-08
CA1312085C (en) 1992-12-29
MX26687A (es) 1994-03-31
ES8707933A1 (es) 1987-09-01
EP0167371A3 (en) 1987-06-16
ATE61356T1 (de) 1991-03-15
EP0167371B1 (en) 1991-03-06
US4727082A (en) 1988-02-23
CA1300157C (en) 1992-05-05
ES544647A0 (es) 1987-09-01
ES552336A0 (es) 1987-04-16
KR900005019B1 (ko) 1990-07-18
AU569161B2 (en) 1988-01-21
ES8704898A1 (es) 1987-04-16
AU4396785A (en) 1986-01-02
KR860000261A (ko) 1986-01-27
DE3581967D1 (de) 1991-04-11
JPH0123463B2 (es) 1989-05-02
PT80714A (en) 1985-07-01

Similar Documents

Publication Publication Date Title
FI850140L (fi) Kemiska foereningar.
DE69514367D1 (de) Substituierte amidderivate
BR9815377A (pt) Derivados de sulfonil
BR9713417A (pt) Composto de açúcar, agente gelificante, composição de agente gelificante, processos para suas preparações e composição de gel.
EP0902007A4 (en) CHALCON DERIVATIVES AND MEDICINES THAT CONTAIN THEM
EA200000677A1 (ru) Фунгицидная смесь на базе амидных соединений и производных пиридина
NO161564C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive beta-carbolin-3-oxadiazolylderivater.
IS5588A (is) Æxliseyðandi miðlar
MX7533E (es) Procedimiento para preparar derivados de dihidropiridina
FR2672801B1 (fr) Utilisation de derives de tetrahydrothienopyridine comme inhibiteurs de l'angiogenese.
ES2091489T3 (es) Derivados de imidazol y composiciones farmaceuticas que los contienen.
KR880002828A (ko) 디하이드로피리딘 유도체 및 이것의 약학적 조성말
NO159927C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aromatiske aminoacetylener.
AU557533B2 (en) Oxadithiadiaza, dioxaselenadiaza, dioxatelluradiaza, and dioxathiadiaza-2,5-pentalene derivatives
KR920006317A (ko) 칼슘 흡수 억제제
NO168580C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive beta-methylen-furanethanaminer
PT84367B (pt) Processo para a preparacao de uma composicao fungicida contendo uma naftimidazolona
RU95102788A (ru) Производные бензоилхинолина, их кислотноаддитивные соли и комплексы солей металлов и фунгицидное средство на их основе
KR890016023A (ko) 1-디메틸카바모일-3-치환된-5-치환된-1h-1,2,4-트리아졸, 이를 함유한 조성물 및 그 사용방법
ES2053808T3 (es) Nuevos compuestos azolicos.
DK84785D0 (da) Kinatsalte af antimalariaforbindelsen mefloquin
SE8500963D0 (sv) Nitraminodiaryl sulfoxide derivatives, process for their preparation and pharmaceutical and pesticidal compositions containing them